As Nader mentioned Thursday evening in the Phillip
Post# of 148160
I suspect the primary reason for this is because the primary endpoint is so simple and obvious.
If CD12 morality reduction is 30% or better the primary endpoint is hit, and everyone can move quickly to offer EUA.
The US FDA and UK MHRA know that they want to see the mortality reduction as soon as possible so they can be prepared to proceed?